Article
The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.
International journal of molecular sciences - 17 Jun 2022
Skoblar Vidmar Marija, Doma Andrej, Smrdel Uroš, Zevnik Katarina, Studen Andrej
Abstract excerpt
The evaluation of treatment response remains a challenge in glioma cases because the neuro oncological therapy can lead to the development of treatment-related changes (TRC) that mimic true progression (TP). Positron emission tomography (PET) using O-(2-[18F] fluoroethyl-)-L-tyrosine (18F-FET) has been shown to be a useful tool for detecting TRC and TP. We assessed the diagnostic performance of different 18F-FET...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
